News
Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.
Patients who received subcutaneous 0.05% chlorhexidine gluconate antisepsis during primary total shoulder arthroplasty had a ...
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results